Hjem › Diffus sclerodermi › South Carolina
Diffus sclerodermi kliniske forsøg i South Carolina
3 studier for Diffus sclerodermi søger deltagere på steder i South Carolina.
Byer i South Carolina
Officiel studietekst (engelsk)
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Medical University of South Carolina, Charleston
- Prisma Health, Greenville
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104Platform Clinical Study for Conquering Scleroderma
- Medical University of South Carolina (MUSC), Charleston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Charleston, Charleston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06991114Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.